Literature DB >> 10963601

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

P J Coopman1, M T Do, M Barth, E T Bowden, A J Hayes, E Basyuk, J K Blancato, P R Vezza, S W McLeskey, P H Mangeat, S C Mueller.   

Abstract

Syk is a protein tyrosine kinase that is widely expressed in haematopoietic cells. It is involved in coupling activated immunoreceptors to downstream signalling events that mediate diverse cellular responses including proliferation, differentiation and phagocytosis. Syk expression has been reported in cell lines of epithelial origin, but its function in these cells remains unknown. Here we show that Syk is commonly expressed in normal human breast tissue, benign breast lesions and low-tumorigenic breast cancer cell lines. Syk messenger RNA and protein, however, are low or undetectable in invasive breast carcinoma tissue and cell lines. Transfection of wild-type Syk into a Syk-negative breast cancer cell line markedly inhibited its tumour growth and metastasis formation in athymic mice. Conversely, overexpression of a kinase-deficient Syk in a Syk-positive breast cancer cell line significantly increased its tumour incidence and growth. Suppression of tumour growth by the reintroduction of Syk appeared to be the result of aberrant mitosis and cytokinesis. We propose that Syk is a potent modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963601     DOI: 10.1038/35021086

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  110 in total

1.  Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.

Authors:  Xi Wang; Ping Gao; Min Long; Fang Lin; Jun-Xia Wei; Ji-Hong Ren; Lin Yan; Ting He; Yuan Han; Hui-Zhong Zhang
Journal:  Med Oncol       Date:  2010-05-11       Impact factor: 3.064

Review 2.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Authors:  Liang Xue; Wen-Horng Wang; Anton Iliuk; Lianghai Hu; Jacob A Galan; Shuai Yu; Michael Hans; Robert L Geahlen; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

4.  Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo.

Authors:  D Chan; J W Tyner; W J Chng; C Bi; R Okamoto; J Said; B D Ngan; G D Braunstein; H P Koeffler
Journal:  Oncol Lett       Date:  2012-01-20       Impact factor: 2.967

Review 5.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

6.  In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers.

Authors:  Anton B Iliuk; Victoria A Martin; Bethany M Alicie; Robert L Geahlen; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2010-06-17       Impact factor: 5.911

7.  An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.

Authors:  Susan R Ross; John W Schmidt; Elad Katz; Laura Cappelli; Stacy Hultine; Phyllis Gimotty; John G Monroe
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

Authors:  Edward H Cho; Rebecca A Whipple; Michael A Matrone; Eric M Balzer; Stuart S Martin
Journal:  Cancer Biol Ther       Date:  2010-01-28       Impact factor: 4.742

9.  Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.

Authors:  Olivier Bailet; Nina Fenouille; Patricia Abbe; Guillaume Robert; Stéphane Rocchi; Nadège Gonthier; Christophe Denoyelle; Michel Ticchioni; Jean-Paul Ortonne; Robert Ballotti; Marcel Deckert; Sophie Tartare-Deckert
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

10.  The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters.

Authors:  Marion Lösing; Ingo Goldbeck; Birgit Manno; Thomas Oellerich; Tim Schnyder; Hanibal Bohnenberger; Björn Stork; Henning Urlaub; Facundo D Batista; Jürgen Wienands; Michael Engelke
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.